The pharmacokinetic parameters of the intravenous anesthetic drug propofol were investigated. Propofol was administered using an infusion pump at variable rates (10, 8, 6 and 4 mg/kg/hr) to 15 Japanese patients undergoing surgery, as part of a protocol for the induction of general anesthesia that included the use of nitrous oxide and muscle relaxants.
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were determined using high performance liquid chromatography and ECD detection. Blood propofol concentrations were also measured when the patients awoke. The blood propofol concentrations were fitted by a three-compartment model using the maximum likelihood estimation. Bias, accuracy and precision between the measured and the predicted blood concentrations were calculated using the pharmacokinetic parameters obtained.
The obtained elimination clearance (CL) , of 49 ml/kg/min, was greater than that 
A continuous infusion device (Terfusion (R)
STC-525X, Terumo) was used for propofol administration.
Anesthesia
For induction of anesthesia, 2 mg/kg propofol was administered to the patients as a single bolus infusion using the infusion pump. Tables 1 and 2 In the present study, the pharmacokinetic of the patients in our study : mean weight of patients in our study was 56 kg compared to 71 kg in previous studies1). 
